Tretinoin and Arsenic Trioxide With or Without Idarubicin in Treating Patients With Acute Promyelocytic Leukemia

NCT00528450 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped Lack of accrual

Conditions

Leukemia

Interventions

DRUG: arsenic trioxide
DRUG: idarubicin
DRUG: tretinoin

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]
[object Object]